Molecular testing of cytological lung cancer specimens includes, beyond epidermal growth factor receptor (EGFR), emerging predictive/prognostic genomic biomarkers such as Kirsten rat sarcoma viral oncogene homolog (KRAS), neuroblastoma RAS viral [v-ras] oncogene homolog (NRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA). Next-generation sequencing (NGS) and other multigene mutational assays are suitable for cytological specimens, including smears. However, the current literature reflects single-institution studies rather than multicenter experiences.

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens / Malapelle, U., Mayo-de-Las-Casas, C., Molina-Vila, M.a., Rosell, R., Savic, S., Bihl, M., Bubendorf, L., Salto-Tellez, M., de Biase, D., Tallini, G., Hwang, D.h., Sholl, L.m., Luthra, R., Weynand, B., Vander Borght, S., Missiaglia, E., Bongiovanni, M., Stieber, D., Vielh, P., Schmitt, F., et al.. - In: CANCER CYTOPATHOLOGY. - ISSN 1934-662X. - (2017). [10.1002/cncy.21868]

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens

Malapelle U;Pepe F;Pisapia P;Vigliar E
Methodology
;
Bellevicine C;Troncone G
2017

Abstract

Molecular testing of cytological lung cancer specimens includes, beyond epidermal growth factor receptor (EGFR), emerging predictive/prognostic genomic biomarkers such as Kirsten rat sarcoma viral oncogene homolog (KRAS), neuroblastoma RAS viral [v-ras] oncogene homolog (NRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA). Next-generation sequencing (NGS) and other multigene mutational assays are suitable for cytological specimens, including smears. However, the current literature reflects single-institution studies rather than multicenter experiences.
2017
Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens / Malapelle, U., Mayo-de-Las-Casas, C., Molina-Vila, M.a., Rosell, R., Savic, S., Bihl, M., Bubendorf, L., Salto-Tellez, M., de Biase, D., Tallini, G., Hwang, D.h., Sholl, L.m., Luthra, R., Weynand, B., Vander Borght, S., Missiaglia, E., Bongiovanni, M., Stieber, D., Vielh, P., Schmitt, F., et al.. - In: CANCER CYTOPATHOLOGY. - ISSN 1934-662X. - (2017). [10.1002/cncy.21868]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/757799
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 66
  • ???jsp.display-item.citation.isi??? 58
social impact